Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.
about
Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects.Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma.Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.
P2860
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Outcomes in patients with mult ...... opoietic stem cell transplant.
@en
type
label
Outcomes in patients with mult ...... opoietic stem cell transplant.
@en
prefLabel
Outcomes in patients with mult ...... opoietic stem cell transplant.
@en
P2093
P2860
P356
P1476
Outcomes in patients with mult ...... opoietic stem cell transplant.
@en
P2093
Elisabet E Manasanch
Fabian Bock
Gabriela Rondon
Jatin J Shah
Jonathan E Brammer
Krina Patel
Muzaffar H Qazilbash
Qaiser Bashir
P2860
P304
P356
10.1002/AJH.24487
P577
2016-07-15T00:00:00Z